StockData
Medicus Pharma Ltd. logo

Medicus Pharma Ltd. (MDCXW) stock

MDCXWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCX
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 5/30
$0.21+0.00 (0.00%)

Close on Oct 30, 2026Market cap $118.78MP/E –Yield –

Medicus Pharma statistics

54 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Oct 30, 2026

Valuation ratiosIndustry

Market Cap
$118.78M
$265.71M
Enterprise Value
$103.64M
$146.54M

Share statisticsIndustry

Shares Change (YoY)
157.0%
10.8%
Shares Change (QoQ)
50.4%
0.54%
Float
46M
49M
Shares Held by Insiders
26.7%
11.4%
Shares Held by Institutions
0.18%
56.1%

Short sellingIndustry

Short Interest
4M
–
Short Interest Change
-26.2%
0.60%
Days to Cover
1.00
4.58

Stock price statisticsIndustry

52-Week High
$130.00
–
52-Week Low
$1.82
–
20-Day Moving Average
$3.77
–
50-Day Moving Average
$7.27
–
200-Day Moving Average
$22.85
–
Average True Range (14)
$0.56
–
Price Change (1 Week)
-24.8%
1.30%
Price Change (1 Month)
-76.1%
-7.60%
Price Change (3 Months)
-87.5%
-14.4%
Price Change (6 Months)
-86.8%
-19.7%
Price Change (YTD)
-97.5%
-19.6%
Price Change (1 Year)
-98.4%
-21.9%
Average Volume (10 Days)
66,600
–
Average Volume (20 Days)
90,036
–
Average Volume (90 Days)
83,973
–
Relative Volume
1.04
0.73
Relative Strength Index (14)
16.5
44.2
Volatility (1 Year)
135.3%
79.5%
Beta (5 Years)
1.38
1.07

Returns on capitalIndustry

Return on Assets (ROA)
-290.2%
-40.9%
Return on Capital Employed (ROCE)
-171.2%
-38.6%

Financial positionIndustry

Current Ratio
1.57
3.30
Quick Ratio
1.40
2.39

EfficiencyIndustry

Profits Per Employee
-$3.54M
-$705.27K
Employee Count
16
75
WACC
11.9%
10.1%

Income statement (TTM)Industry

Operating Income
-$27.87M
-$21.42M
Net Income
-$56.66M
-$22.46M
EBITDA
-$27.87M
-$16.82M
EPS (Diluted)
-$2.45
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$15.17M
$15.31M
Net Cash Per Share
$0.24
$0.66
Equity (Book Value)
-$1.76M
$48.79M
Book Value Per Share
-$0.03
$1.36
Tangible Book Value
-$1.76M
$23.91M
Working Capital
$6.14M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
-$29.32M
-$12.24M

Dividends and yieldsIndustry

Earnings Yield
-47.7%
-20.7%
Buyback Yield
0.00%
-0.51%
Shareholder Yield
0.00%
0.00%

Scores and fair valueIndustry

Altman Z-Score
-5.04
0.25
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.

PeriodMDCXWS&P 500DifferenceMDCXW per yearS&P 500 per year
1 month-30.0%-0.9%−29.1 pts
3 months-32.3%+2.1%−34.4 pts
Year to date-73.8%+11.7%−85.4 pts
1 year-79.8%+12.4%−92.2 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.

0M MDCXW shares were sold short on Oct 15, 2026, down 8.4% from the previous report. At recent volumes it would take 28.0 days to buy them back. Over the last 20 sessions, 48.5% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 15, 202623,095-8.4%82628.0
Sep 30, 202625,210-8.9%37267.8
Sep 15, 202627,671-6.6%79434.9
Aug 31, 202629,620-0.0%53558.9
Aug 14, 202629,621-0.0%57951.2
Jul 31, 202629,622-2.9%2,39112.4
Jul 15, 202630,509-1.0%10,8742.8
Jun 30, 202630,802-9.3%2,52612.2
Jun 15, 202633,942+0.2%1,55721.8
May 29, 202633,874-17.4%96935.0
May 15, 202641,020-1.3%3,99010.3
Apr 30, 202641,576-8.4%1,67624.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.